AIMC Topic: Botulinum Toxins, Type A

Clear Filters Showing 11 to 20 of 21 articles

Voice analysis in adductor spasmodic dysphonia: Objective diagnosis and response to botulinum toxin.

Parkinsonism & related disorders
INTRODUCTION: Adductor-type spasmodic dysphonia is a task-specific focal dystonia characterized by involuntary laryngeal muscle spasms. Due to the lack of quantitative instrumental tools, voice assessment in patients with adductor-type spasmodic dysp...

Effects of robot-assisted gait training in chronic stroke patients treated by botulinum toxin-a: A pivotal study.

Physiotherapy research international : the journal for researchers and clinicians in physical therapy
OBJECTIVE: To investigate combined effects of robot-assisted training (RAT) and physical therapy versus physical therapy only on balance and gait function of chronic stroke patients after botulinum toxin-A (BoNT-A) treatment.

Haptic Feedback Manipulation During Botulinum Toxin Injection Therapy for Focal Hand Dystonia Patients: A Possible New Assistive Strategy.

IEEE transactions on haptics
Abnormality of sensorimotor integration in the basal ganglia and cortex has been reported in the literature for patients with task-specific focal hand dystonia (FHD). In this study, we investigate the effect of manipulation of kinesthetic input in pe...

Combined effects of robot‑assisted gait training and botulinum toxin type A on spastic equinus foot in patients with chronic stroke: a pilot, single blind, randomized controlled trial.

European journal of physical and rehabilitation medicine
BACKGROUND: Despite the growing evidence about the use of robotic gait training in neurorehabilitation, there is a scant literature about the combined effects of this innovative technological approach and a first‑line treatment for focal spasticity a...

Botulinum toxin injection in the pediatric population with medically refractory neuropathic bladder.

Journal of pediatric urology
INTRODUCTION: Botulinum toxin injection (BTI) has been advocated as a second line therapy in management of neuropathic bladder in pediatric population for refractory patients to conventional medical management such as anticholinergics. The purpose wa...

Assessment of artificial intelligence performance in answering questions on onabotulinum toxin and sacral neuromodulation.

Investigative and clinical urology
PURPOSE: This study aimed to evaluate the performance of three artificial intelligence (AI) models-ChatGPT, Gemini, and Copilot-in addressing clinically relevant questions about onabotulinum toxin and sacral neuromodulation (SNM) for the management o...

Artificial Intelligence-Generated Educational Curriculum on Facial Neurotoxin Injections: Assessment of Educational Content, Curriculum Structure, and Course Logistics.

Journal of drugs in dermatology : JDD
BACKGROUND: Large language models (LLMs) have revolutionized the way physicians access and leverage artificial intelligence (AI). The potential role of AI in facilitating aesthetic medical education remains to be established.

Evaluating the Impact of BoNT-A Injections on Facial Expressions: A Deep Learning Analysis.

Aesthetic surgery journal
BACKGROUND: Botulinum toxin type A (BoNT-A) injections are widely administered for facial rejuvenation, but their effects on facial expressions remain unclear.

Clinical Uses of a Robot (Hybrid-Assisted Limb or HAL™) in Patients with Post-stroke Spasticity after Botulinum Toxin Injections.

The journal of medical investigation : JMI
Spasticity is the major cause of disabilities in stroke-survivors. Botulinum neurotoxin (BoNT) injections have been used to reduce the muscle tone in those patients, but its efficacy in functional outcome is not well delineated. We have studied the e...